Contributor Page
Singh & Associates
 
Email  |  Website  |  Articles
Contact Details
Tel: +91 11 46667000
Fax: +91 11 46667001
E-337, East of Kailash
New Delhi
110065
India
Awards
Contributor Most Read
Contributor Most Read
Contributor Most Read
Contributor Most Read
Contributor Most Read
By Aayush Sharma
The Indian Patent Office has taken various measures for the betterment of Intellectual Property in the country.
By Shrimant Singh
The Patents Act, 1970, and the Patents Rules, 2003, have undergone number of changes in last one decade or so.
By Shrabani Rout, Shreyasi Tiwari
The Court granted partial summary judgment to the plaintiff.
By Heena Lamba
Before discussing the status of patenting of blockchain services in India, let us first have a look at what blockchain services are -
By Shrimant Singh
Advancement in current technologies and innovation are essential for a company offering digital products or services even for their survival.
By Samridh Ahuja
The author through this article aims to focus on the principle of "acquired distinctiveness" in the Indian trademark law and establish how proviso to Section 9 (1)(b) of the Indian Trade Marks Act...
By Singh & Associates
On June 12, 2018, USFDA released the draft guidance on ‘Patient-Focused Drug Development: Collecting Comprehensive and Representative Input' for Industry, Food and Drug Administration...
By Singh & Associates
On June 25, 2018, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy...
By Singh & Associates
This release is an advance preview that will allow countries to plan how to use the new version, prepare translations, and train health professionals all over the country.
By Singh & Associates
Kymriah will be available as a dispersion for infusion.
By Singh & Associates
IRIS is the online web portal through which applicants can apply to the EMA for orphan designation for a medicine.
By Singh & Associates
The Ministry of Health and Family Welfare, on March 16, 2018, has notified that tuberculosis is a dangerous epidemic disease, a threat to life and is a major public health problem accounting...
By Singh & Associates
The Office of the Registrar General, India, under the Ministry of Home Affairs, has released special Sample Registration System (SRS) Bulletin on Maternal Mortality in India 2014-2016.
By Singh & Associates
On June 19, 2018, Strides Shasun announced the receipt of prequalification from the World Health Organization for their 100mg Rectal Artesunate Suppositories for the pre-referral management of severe malaria.
By Singh & Associates
The Competition Commission of India (CCI) is an administrative or regulatory body formed under the Competition Act 2002 (as amended vide Competition (Amendment) Act 2007, and hereinafter referred to as the ‘Act").
Contributor's Topics
More...